Data Sheet 1_Continuation of atezolizumab plus bevacizumab beyond initial progressive disease: clinical benefits in patients with unresectable hepatocellular carcinoma – a multicenter cohort study.pdf

Data Sheet 1_Continuation of atezolizumab plus bevacizumab beyond initial progressive disease: clinical benefits in patients with unresectable hepatocellular carcinoma – a multicenter cohort study.pdf

Background<p>The clinical significance of treatment beyond progression (TBP) with immune checkpoint inhibitor-based therapy in hepatocellular carcinoma (HCC) remains unclear. As atezolizumab plus bevacizumab has become a first-line therapy for advanced HCC, understanding the real-world outcome...

Full description

Saved in:
Bibliographic Details
Main Author: Takaya Tabuchi (10634815) (author)
Other Authors: Nobuhito Taniki (549431) (author), Keisuke Ojiro (193783) (author), Ryosuke Kasuga (10634812) (author), Yukie Nakadai (22228993) (author), Po-Sung Chu (13920276) (author), Shingo Usui (549428) (author), Shunsuke Shiba (737622) (author), Toshiyuki Tahara (22228996) (author), Hirokazu Komatsu (209445) (author), Yuriko Fujita (11664038) (author), Fumihiko Kaneko (22228999) (author), Hitomi Hoshi (10634806) (author), Akihiro Yamaguchi (737621) (author), Seiichiro Fukuhara (6063302) (author), Yukishige Okamura (22229002) (author), Hideaki Kanamori (22229005) (author), Hirotoshi Ebinuma (193765) (author), Masashi Tamura (10344744) (author), Jitsuro Tsukada (22229008) (author), Yasushi Hasegawa (14139029) (author), Yuta Abe (369074) (author), Minoru Kitago (3509972) (author), Masahiro Jinzaki (3799930) (author), Yuko Kitagawa (369079) (author), Takanori Kanai (185812) (author), Nobuhiro Nakamoto (267143) (author)
Published: 2025
Subjects:
Genetic Immunology
hepatocellular carcinoma
immune checkpoint inhibitor
atezolizumab plusbevacizumab
treatment sequence
treatment beyond disease progression
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items